A comprehensive guide for healthcare professionals on managing hepatitis C in thalassemia patients, from epidemiology to treatment.
From A to Z on Hepatitis C in Thalassemia
Patients with thalassemia carry a markedly high burden of hepatitis C, and liver disease remains their leading cause of death worldwide. Written for clinicians, this book sets out the epidemiology, screening, diagnosis, and treatment of HCV in a group that many thalassemia centres still have no policy for.
Author
Publisher
Pouyan Kowsar Health Publishing, 1st Edition
Publication date
April 8, 2022
Print length
78 pages
Language
English
ISBN
978-622-99114-6-4
Sponsored by
Salamat Pooyan
Audience
Haematologists, hepatologists, and thalassemia care teams
Read this book
The full text is freely available under a CC BY-NC 4.0 licence for personal, non-commercial use. For commercial use or additional permissions, contact the publisher.
About this book
Patients with thalassemia face a significantly high prevalence of hepatitis C virus infection. Their survival has improved substantially — better control of iron overload, safer transfusion practice, and improved management of complications — yet liver disease remains the leading cause of mortality among thalassemia patients worldwide.
Many thalassemia centres still lack adequate policies for controlling HCV infection, and managing co-infected patients demands professional counselling alongside specialised diagnostic and therapeutic approaches. This book provides comprehensive guidance for health professionals on the epidemiology, screening, diagnosis, and treatment of HCV in this high-risk group, with the aim of improving HCV control globally and particularly across the Mediterranean region.
Contents
Five chapters, from virology to treatment.
| Chapter | Page |
|---|---|
| 1. Virology | 7 |
| 2. Epidemiology | 12 |
| 3. Natural history | 26 |
| 4. Diagnosis and evaluation | 34 |
| 5. Treatment | 42 |
Copyright. This book is published for personal use only under a Creative Commons Attribution Non-Commercial 4.0 License. For commercial use or further permissions, contact the publisher. Also featured on Scinews.